Literature DB >> 8925591

Risk-reduction therapy: the challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995 Anaheim, California.

S C Smith.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8925591     DOI： 10.1161/01.cir.93.12.2205

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  Primary and secondary prevention of heart disease: can we curb the global epidemic?

Authors:  S C Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

2.  Rehabilitation and secondary prevention in patients with cardiovascular diseases.

Authors:  G Maisano; G Molinis; D Tuniz; M Valente
Journal:  Ital J Neurol Sci       Date:  1998-10

3.  Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome.

Authors:  K M J Douglas; A V Pace; G J Treharne; A Saratzis; P Nightingale; N Erb; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

4.  First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era?

Authors:  Steve Ramcharitar; Nieves Gonzalo; Robert Jan van Geuns; Hector M Garcia-Garcia; Joanna J Wykrzykowska; Jurgen M R Ligthart; Evelyn Regar; Patrick W Serruys
Journal:  Nat Rev Cardiol       Date:  2009-05       Impact factor: 32.419

Review 5.  New insights into plaque stabilisation by lipid lowering.

Authors:  P Libby; M Aikawa
Journal:  Drugs       Date:  1998       Impact factor: 9.546

6.  Atherosclerosis: an integrative East-west medicine perspective.

Authors:  Hao Xu; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-05       Impact factor: 2.629

Review 7.  Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis.

Authors:  Chenyi Ye; Mingyuan Xu; Shengdong Wang; Shuai Jiang; Xi Chen; Xiaoyu Zhou; Rongxin He
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.